IVUS-Guided Versus OCT-Guided Coronary Stent Implantation: A Critical Appraisal

JACC: Cardiovascular Imaging

Volumn 10, Issue 12, 2017, Pages 1487-1503

  Maehara, Akiko ^a,b   Matsumura, Mitsuaki ^b   Ali, Ziad A ^a,b   Mintz, Gary S ^b   Stone, Gregg W ^a,b  

^a Department of Orthopaedic Surgery   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

intravascular ultrasound; optical coherence tomography; percutaneous coronary intervention; stent(s)

Indexed keywords

ACUTE DISEASE; CLINICAL OUTCOME; DEVICE FAILURE; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; REVIEW; STENT MALAPPOSITION; TISSUE PROTRUSION; CLINICAL DECISION MAKING; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DEVICES; DIAGNOSTIC IMAGING; INTERVENTIONAL ULTRASONOGRAPHY; PREDICTIVE VALUE; PROCEDURES; PROSTHESIS DESIGN; STENT; TREATMENT OUTCOME;

CLINICAL DECISION-MAKING; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 85038110817     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2017.09.008     Document Type: Review

References (77)

1. Hoffmann, R., Mintz, G.S., Popma, J.J., et al. Treatment of calcified coronary lesions with Palmaz-Schatz stents. An intravascular ultrasound study. Eur Heart J 19 (1998), 1224–1231.
2. Kobayashi, Y., Okura, H., Kume, T., et al. Impact of target lesion coronary calcification on stent expansion. Circ J 78 (2014), 2209–2214.
3. Chieffo, A., Latib, A., Caussin, C., et al. A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J 165 (2013), 65–72.
4. Witzenbichler, B., Maehara, A., Weisz, G., et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the Assessment Of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Circulation 129 (2014), 463–470.
5. Ali, Z.A., Maehara, A., Généreux, P., et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial. Lancet 388 (2016), 2618–2628.
6. Liu, J., Maehara, A., Mintz, G.S., et al. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. Am J Cardiol 103 (2009), 501–506.
7. Kang, S.J., Cho, Y.R., Park, G.M., et al. Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation. Am J Cardiol 111 (2013), 1408–1414.
8. Ino, Y., Kubo, T., Matsuo, Y., et al. Optical coherence tomography predictors for edge restenosis after everolimus-eluting stent implantation. Circ Cardiovasc Interv, 9, 2016, e004231.
9. Moussa, I., Moses, J., Di Mario, C., et al. Does the specific intravascular ultrasound criterion used to optimize stent expansion have an impact on the probability of stent restenosis?. Am J Cardiol 83 (1999), 1012–1017.
10. Kang, S.J., Ahn, J.M., Song, H., et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv 4 (2011), 562–569.
11. Doi, H., Maehara, A., Mintz, G.S., et al. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. J Am Coll Cardiol Intv 2 (2009), 1269–1275.
12. Song, H.G., Kang, S.J., Ahn, J.M., et al. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Catheter Cardiovasc Interv 83 (2014), 873–878.
13. Choi, S.Y., Maehara, A., Cristea, E., et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy. Am J Cardiol 109 (2012), 455–460.
14. Fujii, K., Carlier, S.G., Mintz, G.S., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005), 995–998.
15. Liu, X., Doi, H., Maehara, A., et al. A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. J Am Coll Cardiol Intv 5 (2009), 428–434.
16. Choi, S.Y., Witzenbichler, B., Maehara, A., et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy. Circ Cardiovasc Interv 4 (2011), 239–247.
17. Soeda, T., Uemura, S., Park, S.J., et al. Incidence and clinical significance of poststent optical coherence tomography findings: one-year follow-up study from a multicenter registry. Circulation 132 (2015), 1020–1029.
18. Prati, F., Romagnoli, E., Burzotta, F., et al. Clinical Impact of OCT Findings During PCI: the CLI-OPCI II Study. J Am Coll Cardiol Img 8 (2015), 1297–1305.
19. Im, E., Kim, B.K., Ko, Y.G., et al. Incidence, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. Circ Cardiovasc Interv 7 (2014), 88–96.
20. Romagnoli, E., Gatto, L., La Manna, A., et al. Role of residual acute stent malapposition in percutaneous coronary interventions. Catheter Cardiovasc Interv 90 (2017), 566–575.
21. Prati, F., Kodama, T., Romagnoli, E., et al. Suboptimal stent deployment is associated with subacute stent thrombosis: optical coherence tomography insights from a multicenter matched study. From the CLI Foundation investigators: the CLI-THRO study. Am Heart J 169 (2015), 249–256.
22. Guo, N., Maehara, A., Mintz, G.S., et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Circulation 122 (2010), 1077–1084.
23. Steinberg, D.H., Mintz, G.S., Mandinov, L., et al. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, long lesion, and direct stent studies. J Am Coll Cardiol Intv 3 (2010), 486–494.
24. Wang, B., Mintz, G.S., Witzenbichler, B., et al. Predictors and long-term clinical impact of acute stent malapposition: an Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) intravascular ultrasound substudy. J Am Heart Assoc, 5, 2016, e004438.
25. Kobayashi, N., Mintz, G.S., Witzenbichler, B., et al. Prevalence, features, and prognostic importance of edge dissection after drug-eluting stent implantation: an ADAPT-DES Intravascular Ultrasound Substudy. Circ Cardiovasc Interv, 9, 2016, e003552.
26. Qiu, F., Mintz, G.S., Witzenbichler, B., et al. Prevalence and clinical impact of tissue protrusion after stent implantation: an ADAPT-DES Intravascular Ultrasound Substudy. J Am Coll Cardiol Intv 9 (2016), 1499–1507.
27. Goto, K., Zhao, Z., Matsumura, M., et al. Mechanisms and patterns of intravascular ultrasound in-stent restenosis among bare metal stents and first- and second-generation drug-eluting stents. Am J Cardiol 116 (2015), 1351–1357.
28. Song, L., Mintz, G.S., Yin, D., et al. Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study. EuroIntervention 13 (2017), 294–302.
29. Souteyrand, G., Amabile, N., Mangin, L., et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J 37 (2016), 1208–1216.
30. Tearney, G.J., Regar, E., Akasaka, T., et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 59 (2012), 1058–1072.
31. Di Vito, L., Yoon, J.H., Kato, K., et al. Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses. Coron Artery Dis 25 (2014), 172–185.
32. Mintz, G.S., Nissen, S.E., Anderson, W.D., et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001), 1478–1492.
33. Gerbaud, E., Weisz, G., Tanaka, A., et al. Multi-laboratory inter-institute reproducibility study of IVOCT and IVUS assessments using published consensus document definitions. Eur Heart J Cardiovasc Imaging 17 (2016), 756–764.
34. Glagov, S., Weisenberg, E., Zarins, C.K., Stankunavicius, R., Kolettis, G.J., Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987), 1371–1375.
35. Kubo, T., Akasaka, T., Shite, J., et al. Optical coherence tomography compared to intravascular ultrasound in coronary lesion assessment study: OPUS-CLASS study. J Am Coll Cardiol Img 6 (2013), 1095–1104.
36. Bezerra, H.G., Attizzani, G.F., Sirbu, V., et al. Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention. J Am Coll Cardiol Intv 6 (2013), 228–236.
37. Sawada, T., Shite, J., Negi, N., et al. Factors that influence measurements and accurate evaluation of stent apposition by optical coherence tomography. Assessment using a phantom model. Circ J 73 (2009), 1841–1847.
38. Prati, F., Di Vito, L., Biondi-Zoccai, G., et al. Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention 8 (2012), 823–829.
39. Meneveau, N., Souteyrand, G., Motreff, P., et al. Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: results of the multicenter, randomized DOCTORS (Does Optical Coherence Tomography Optimize Results of Stenting) study. Circulation 134 (2016), 906–917.
40. Habara, M., Nasu, K., Terashima, M., et al. Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implantation in comparison with intravascular ultrasound guidance. Circ Cardiovasc Interv 5 (2012), 193–201.
41. Kubo, T., Shinke, T., Okamura, T., et al. Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results. Eur Heart J 38 (2017), 3139–3147.
42. van der Sijde, J.N., Karanasos, A., van Ditzhuijzen, N.S., et al. Safety of optical coherence tomography in daily practice: a comparison with intravascular ultrasound. Eur Heart J Cardiovasc Imaging 18 (2017), 467–474.
43. Patel, V.G., Brayton, K.M., Mintz, G.S., et al. Intracoronary and noninvasive imaging for prediction of distal embolization and periprocedural myocardial infarction during native coronary artery percutaneous intervention. Circ Cardiovasc Imaging 6 (2013), 1102–1114.
44. Kimura, S., Kakuta, T., Yonetsu, T., et al. Clinical significance of echo signal attenuation on intravascular ultrasound in patients with coronary artery disease. Circ Cardiovasc Interv 2 (2009), 444–454.
45. Endo, M., Hibi, K., Shimizu, T., et al. Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 3 (2010), 540–549.
46. Ali, Z.A., Roleder, T., Narula, J., et al. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv 6 (2013), 507–517.
47. Pu, J., Mintz, G.S., Biro, S., et al. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments. J Am Coll Cardiol 63 (2014), 2220–2233.
48. Kostamaa, H., Donovan, J., Kasaoka, S., Tobis, J., Fitzpatrick, L., Calcified plaque cross-sectional area in human arteries: correlation between intravascular ultrasound and undecalcified histology. Am Heart J 137 (1999), 482–488.
49. Friedrich, G.J., Moes, N.Y., Mühlberger, V.A., et al. Detection of intralesional calcium by intracoronary ultrasound depends on the histologic pattern. Am Heart J 128 (1994), 435–441.
50. Mintz, G.S., Popma, J.J., Pichard, A.D., et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 91 (1995), 1959–1965.
51. Maejima, N., Hibi, K., Saka, K., et al. Relationship between thickness of calcium on optical coherence tomography and crack formation after balloon dilatation in calcified plaque requiring rotational atherectomy. Circ J 80 (2016), 1413–1419.
52. Kubo, T., Shimamura, K., Ino, Y., et al. Superficial calcium fracture After PCI as assessed by OCT. J Am Coll Cardiol Img 10 (2015), 1228–1229.
53. de Jaegere, P., Mudra, H., Figulla, H., et al. Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 19 (1998), 1214–1223.
54. Mintz, G.S., Painter, J.A., Pichard, A.D., et al. Atherosclerosis in angiographically “normal” coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 25 (1995), 1479–1485.
55. Costa, M.A., Angiolillo, D.J., Tannenbaum, M., et al. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol 101 (2008), 1704–1711.
56. Koyama K. A Prospective, Single-Center, Randomized Study to Assess Whether Co-registration of OCT and Angiography Can Reduce Geographic Miss. TCTMD. October 2016. Available at: https://www.tctmd.com/slide/prospective-single-center-randomized-study-assess-whether-co-registration-oct-and-angiography. Accessed March 13, 2017.
57. Zhang, Y., Farooq, V., Garcia-Garcia, H.M., et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention 8 (2012), 855–865.
58. Ahn, J.M., Kang, S.J., Yoon, S.H., et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol 113 (2014), 1338–1347.
59. Zhang, Y.J., Pang, S., Chen, X.Y., et al. Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis. BMC Cardiovasc Disord, 15, 2015, 153.
60. Hong, S.J., Kim, B.K., Shin, D.H., et al. Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA 314 (2015), 2155–2163.
61. Elgendy, I.Y., Mahmoud, A.N., Elgendy, A.Y., Bavry, A.A., Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents. Circ Cardiovasc Interv, 9, 2016, e003700.
62. Steinvil, A., Chang, Y.J., Lee, S.Y., et al. Intravascular ultrasound-guided drug-eluting stent implantation: an updated meta-analysis of randomized control trials and observational studies. Int J Cardiol 216 (2016), 133–139.
63. Bavishi, C., Sardar, P., Chatterjee, S., et al. Intravascular ultrasound-guided vs angiography-guided drug-eluting stent implantation in complex coronary lesions: meta-analysis of randomized trials. Am Heart J 185 (2017), 26–34.
64. de la Torre Hernandez, J.M., Baz Alonso, J.A., Gómez Hospital, J.A., et al. Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries. J Am Coll Cardiol Intv 7 (2014), 244–254.
65. Park, S.J., Kim, Y.H., Park, D.W., et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv 2 (2009), 167–177.
66. Andell, P., Karlsson, S., Mohammad, M.A., et al. Intravascular ultrasound guidance is associated with better outcome in patients undergoing unprotected left main coronary artery stenting compared with angiography guidance alone. Circ Cardiovasc Interv, 10, 2017, e004813.
67. Alberti, A., Giudice, P., Gelera, A., et al. Understanding the economic impact of intravascular ultrasound (IVUS). Eur J Health Econ 17 (2016), 185–193.
68. Ishibashi, Y., Nakatani, S., Sotomi, Y., et al. Relation between bioresorbable scaffold sizing using QCA-Dmax and clinical outcomes at 1 year in 1,232 patients from 3 study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II). J Am Coll Cardiol Intv 8 (2015), 1715–1726.
69. Puricel, S., Cuculi, F., Weissner, M., et al. Bioresorbable coronary scaffold thrombosis. J Am Coll Cardiol 67 (2016), 921–931.
70. Ellis SG. Everolimus-Eluting Bioresorbable Vascular Scaffolds in Patients with Coronary Artery Disease: ABSORB III Trial 2-Year Results. TCTMD. March 2017. Available at: https://www.tctmd.com/slide/everolimus-eluting-bioresorbable-vascular-scaffolds-patients-coronary-artery-disease-absorb. Accessed July 30, 2017.
71. Tanaka, A., Latib, A., Kawamoto, H., et al. Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy. EuroIntervention 12 (2017), 1730–1737.
72. Hassan, A.K., Bergheanu, S.C., Stijnen, T., et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 31 (2010), 1172–1180.
73. Won, H., Shin, D.H., Kim, B.K., et al. Optical coherence tomography derived cut-off value of uncovered stent struts to predict adverse clinical outcomes after drug-eluting stent implantation. Int J Cardiovasc Imaging 29 (2013), 1255–1263.
74. Armstrong, E.J., Feldman, D.N., Wang, T.Y., et al. Clinical presentation, management, and outcomes of angiographically documented early, later, and very late stent thrombosis. J Am Coll Cardiol Intv 5 (2012), 131–140.
75. Sotomi, Y., Suwannasom, P., Serruys, P.W., Onuma, Y., Possible mechanical causes of scaffold thrombosis: insights from case reports with intracoronary imaging. EuroIntervention 12 (2017), 1747–1756.
76. Li, B.H., Leung, A.S., Soong, A., et al. Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis. Catheter Cardiovasc Interv 81 (2013), 494–507.
77. Ramalingam R. Development and Testing of a Novel and Smart Hybrid IVUS-OCT Sensor for Intravascular Ultrasound. Available at: https://events.eventact.com/ProgramView/ViewAbstract.aspx?Abst=131952&Code=1872739 Accessed on July 31, 2017.